PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The Faculty of Biology, Medicine and Health and Manchester Academic Health Sciences Centre, University of Manchester, UK.\', \'Department of Diabetes and Endocrinology, Salford Royal Hospitals, Salford, UK.\', \'Res Consortium, Andover, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/ijcp.14341
?:doi
?:hasPublicationType
?:journal
  • International journal of clinical practice
is ?:pmid of
?:pmid
?:pmid
  • 33963659
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.892
?:rankingScore_hIndex
  • 84
is ?:relation_isRelatedTo_publication of
?:title
  • Comparing cost of intravenous infusion and subcutaneous biologics in COVID-19 pandemic care pathways for rheumatoid arthritis and inflammatory bowel disease: A brief UK stakeholder survey.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all